What? I’m not losing data! Actually you are. It is correct; you have not had a major IT system crash in years. And even if you did, systems are being backed up on a regular basis and are recoverable. And, it is true; you may have had issues with people storing data in the wrong […]
In spite of recent advances in science and technology, the next great innovation in drug research and development is not going to be a major breakthrough in cancer, HIV, or some other research. That is; an increase in sustained profits will not be as a result of introducing a new breakthrough drug on the market. […]
There are tremendous advantages from being on the same page. Think of a stringed quartet. If they are not all on the same page, the harmonies produced by their instruments will not exist and the audience will walk out. The same principle can be applied to the drug research process. If all participants are not […]
Advanced technology accelerates pharmaceutical research and development February 03, 2016 08:00 AM Eastern Standard Time SILVER SPRING, Md.–(BUSINESS WIRE)–Aurotech Inc. announces the launch of the Drug Lifecycle Tracking Application (DLTA). Through DLTA, Aurotech helps companies simplify work and process management across the entire drug development cycle. Pharmaceutical and contract research organizations (CROs) are under constant […]
This week I attended DIA Global‘s forum on Regulatory Submission, Information and Document Management. The key take away I had was that the ongoing pharmaceutical pain points have not been addressed by any technological solution. There are solutions that target and address a subset of these pain points but the pharma industry hasn’t had an […]
The Drug Lifecycle Tracking Application is a cloud-based work management solution developed specifically for the pharmaceutical industry that maps and tracks the entire lifecycle of a drug being developed, including the FDA’s drug approval and post-approval processes and activities. DLTA provides the industry with a solution that is detailed and complete with built-in durations and […]
Developing new drugs requires managing highly complex processes that span over several years and involves the collaboration of multiple resource groups. Having to manage this complex maze of workflows and simultaneously navigate through FDA’s regulatory requirements with no central engine has led to fragmentation within pharmaceutical organizations. A fragmented workspace leads to confusion, work duplication, […]